Smart Pillbox Secures RMB 6 Million in Angel Funding to Build a Precision Patient Medication Data Platform
Smart Medicine Box Team
On June 16, “Smart Medicine Box,” a mobile-based precision patient medication data service platform, announced that it had secured RMB 6 million in angel-round funding from Hongli Venture Capital. Smart Medicine Box is a subsidiary of Zhixiang Health Technology (Beijing) Co., Ltd. Liu Quan, founder and CEO of the company, stated that the funds would be primarily used to accelerate the development of its big data-plus-service platform for patient medication, and to establish in-depth collaborations with pharmaceutical companies on patient management systems. This will further consolidate the company’s core competencies and leading position in both consumer-facing personalized medication management and business-facing precision patient marketing.
In the traditional pharmaceutical marketing environment, pharmaceutical companies and patients are heavily separated. Drugs can only reach patients through hospitals or pharmacies, and pharmaceutical companies’ product sales and patient services largely depend on these channels, making brand building extremely challenging. The innovation of the smart medicine box lies in connecting pharmaceutical companies with users through the QR code scanning points and coupon distribution features of WeChat Service Accounts. Pharmaceutical companies can dynamically capture sales-related data such as patient characteristics, medication records, and geographic distribution, thereby identifying the users of each individual drug box and enabling precise, user-oriented marketing.
After scanning the medication code, users can access dynamic, personalized medication knowledge and comprehensive management of the entire drug therapy process. This includes alerts on potential side effects and their management, food-drug interactions that may affect efficacy, contraindications for concurrent use of specific medications, and safety information for pregnant and breastfeeding women. This approach not only significantly improves the health status of general users but also effectively enhances patients' medication adherence, thereby achieving the goals of patient education.
According to Liu Quan, founder of Smart Medicine Box, since its official launch in July 2015, the platform has accumulated over 1.05 million users and recorded more than 3.43 million drug barcode scans. In the past two months, the daily peak of new users has exceeded 27,000, indicating rapid growth. Meanwhile, Smart Medicine Box has established a drug database containing 790,000 entries and compiled personalized “Drug Tips” for 51,000 commonly used medications, with these figures continuing to grow rapidly.
As the user base and user stickiness continue to rise, the commercial value of smart medicine boxes is rapidly becoming apparent. Liu Quan revealed that multiple pharmaceutical companies and chain pharmacies have already joined the smart medicine box platform, and collaborations with pharmaceutical e-commerce and internet healthcare enterprises are actively underway. In recent weeks, "Smart Medicine Box" has partnered with well-known pharmaceutical e-commerce platforms such as Haoyaoshi, Qilekang, Kangaidu, JD Health At-Home, and 111.com (Yiyaowang) to launch a "Joint Brand Promotion Week." By leveraging the big data capabilities of the smart medicine box to target precise user segments for promotions, the initiative has demonstrated strong brand dissemination and user traffic redirection capabilities. According to the head of marketing at 111.com, during the one-week campaign, "Smart Medicine Box" generated 148,000 brand impressions for 111.com, successfully attracting over 50,000 participants, resulting in 4,826 transaction orders, and driving 951 app downloads.
In addition to establishing patient-centric CRM systems for pharmaceutical companies, driving traffic to pharmaceutical e-commerce platforms, and providing third-party medication management services for internet healthcare enterprises, the precise, large-scale medication data segmented by region and population—accumulated through smart medicine boxes—can be leveraged to develop highly promising commercial data services. These services can then be integrated with a broad range of industry clients, including healthcare providers and health insurance companies.
“Smart Medicine Box” investor Virtus Inspire Ventures has invested in more than a dozen healthcare and TMT companies across the United States, Israel, and China. The two partners finalized the term sheet with Liu Quan during their very first meeting. What attracted them to act so swiftly despite the capital winter? “The Smart Medicine Box team is deeply rooted in both pharmaceuticals and data applications. The project does not rely on closed-off medical resources; instead, it can rapidly achieve scale by leveraging market-driven resources. The resulting big data on patient medication usage can be organically integrated with pharmaceutical companies, healthcare providers, and medical e-commerce platforms, offering substantial room for future commercial expansion,” explained Mr. Li Haixiang, Founding Partner of Virtus Inspire Ventures and former Senior Executive Vice President of Tencent Corporation, outlining the rationale behind the investment decision.